Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents

Clinical Infectious Diseases

Volumn 38, Issue 7, 2004, Pages 951-957

  Frenck Jr , Robert W ^a,e   Mansour, Adel ^a   Nakhla, Isabelle ^a   Sultan, Yehia ^b   Putnam, Shannon ^a,d   Wierzba, Thomas ^a   Morsy, Mosaad ^c   Knirsch, Charles ^c  

^a US Naval Medical Research Unit No 3 Egypt   (Egypt)

^b ABBASSIA FEVER HOSPITAL   (Egypt)

^c PFIZER INC   (United States)

^d US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^e Enteric Disease Research Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; DRUG EFFICACY; FECES; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; SALMONELLA ENTERICA; SALMONELLA PARATYPHI; SHORT COURSE THERAPY; TYPHOID FEVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; RANDOMIZED CONTROLLED TRIAL; SALMONELLA TYPHI; SALMONELLOSIS; TREATMENT OUTCOME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; FEMALE; HUMANS; MALE; SALMONELLA INFECTIONS; SALMONELLA PARATYPHI A; SALMONELLA TYPHI; TREATMENT OUTCOME; TYPHOID FEVER;

EID: 1842607753     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/382359     Document Type: Article

References (27)

1. Ivanoff B, Levine MM, Lambert PH. Vaccination against typhoid fever: present status. Bull World Health Organ 1994; 72:957-71.
2. Rowe B, Ward LR, Threlfall EJ. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis 1997; 24(Suppl 1):S106-9.
3. Brown JC, Shanahan PM, Jesudason MV, Thomson CJ, Amyes SG. Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India. J Antimicrob Chemother 1996; 37:891-900.
4. Brown NM, Millar MR, Frost JA, Rowe B. Ciprofloxacin resistance in Salmonella paratyphi A. J Antimicrob Chemother 1994; 33:1258-9.
5. Acharya G, Butler T, Ho M, et al. Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol. Am J Trop Med Hyg 1995; 52:162-5.
6. Farid Z, Girgis N, Abu el Ella A. Successful treatment of typhoid fever in children with parenteral ceftriaxone. Scand J Infect Dis 1987; 19: 467-8.
7. Islam A, Butler T, Kabir I, Alam NH. Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial. Antimicrob Agents Chemother 1993; 37:1572-5.
8. Saha SK, Talukder SY, Islam M, Saha S. A highly ceftriaxone-resistant Salmonella typhi in Bangladesh. Pediatr Infect Dis J 1999; 18:387.
9. Vaudaux BP, Cherpillod J, Dayer P. Concentrations of azithromycin in tonsilar and/or adenoid tissue from paediatric patients. J Antimicrob Chemother 1996; 37(Suppl C):45-51.
10. Wildfeuer A, Laufen H, Zimmermann T. Distribution of orally administered azithromycin in various blood compartments. Int J Clin Pharmacol Ther 1994; 32:356-60.
11. Wildfeuer A, Laufen H, Zimmermann T. Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions. Antimicrob Agents Chemother 1996; 40:75-9.
12. Tribble D, Girgis N, Habib N, Butler T. Efficacy of azithromycin for typhoid fever. Clin Infect Dis 1995; 21:1045-6.
13. Girgis NI, Butler T, Frenck RW, et al. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 1999; 43:1441-4.
14. Frenck RW Jr, Nakhla I, Sultan Y, et al. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis 2000; 31:1134-8.
15. Chinh NT, Parry CM, Ly NT, et al. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother 2000; 44:1855-9.
16. Blackwelder WC. 'Proving the null hypothesis' in clinical trials. Controlled Clinical Trials 1982; 3:345-53.
17. Gray L. Escherichia, Salmonella, Shigella and Yersinia. In: Murray PR. Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed, Washington, DO ASM Press, 1995.
18. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by standardized single disk method. Am J Clin Path 1966; 45: 493-6.
19. NCCLS. Performance standards for antimicrobial disk susceptibility tests; approved standard. 8th ed. NCCLS no. M100-S13. Villanova, PA: NCCLS, 1997.
20. Bhutta ZA. Therapeutic aspects of typhoidal salmonellosis in childhood: the Karachi experience. Ann Trop Paediatr 1996; 16:299-306.
21. Dutta P, Mitra U, Dutta S, De A, Chatterjee MK, Bhattacharya SK. Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children. Indian J Med Res 2001; 113:210-3.
22. Lasserre R, Sangalang RP, Santiago L. Three-day treatment of typhoid fever with two different doses of ceftriaxone, compared to 14-day therapy with chloramphenicol: a randomized trial. J Antimicrob Chemother 1991; 28:765-72.
23. Butler T, Sridhar CB, Daga MK, et al. Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother 1999; 44:243-50.
24. Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35: 1265-8.
25. Hasan Z, Rahman KM, Alam MN, et al. Role of a large plasmid in mediation of multiple drug resistance in Salmonella typhi and paratyphi A in Bangladesh. Bangladesh Med Res Counc Bull 1995; 21:50-4.
26. Ranju C, Pais P, Ravindran GD, Singh G. Changing pattern of antibiotic sensitivity of Salmonella typhi. Natl Med J India 1998; 11:266-7.
27. Sood S, Kapil A, Das B, Jain Y, Kabra SK. Re-emergence of chloramphenicol-sensitrve Salmonella typhi. Lancet 1999; 353:1241-2.